About This Fund
TCGX Fund II will invest exclusively in innovative drug discovery companies seeking to make an impact on patients. The fund will invest in visionary entrepreneurs leveraging recent scientific breakthroughs to develop transformative medicines. Investments will be primarily focused on North America and Europe or China based companies doing US drug development. TCGX Fund I, its predecessor, the inaugural fund launched in February 2021, delivered a differentiated track record of M&A and successful IPOs.